Evidence map›Paper›PMID 20005458›Full record

ArticleInternational journal of radiation oncology, biology, physics2010

Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Kimberley S Samkoe, Alina Chen, Imran Rizvi, Julia A O'Hara, P Jack Hoopes, Stephen P Pereira, Tayyaba Hasan, Brian W Pogue

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kimberley S SamkoeThayer School of Engineering, Dartmouth College, Hanover, NH, USA. samkoe@dartmouth.edu; pogue@dartmouth.edu
Alina Chen
Imran Rizvi
Julia A O'Hara
P Jack Hoopes
Stephen P Pereira
Tayyaba Hasan
Brian W Pogue
Dartmouth College · USMassachusetts General Hospital · USUniversity College London · GB

Funding

Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Bryan Quilty Spring · 2001 to 2026
$27.9M
Fluorescence Imaging to Optimize Cancer TherapyR01CA109558 · NCI · DARTMOUTH COLLEGE · PI POGUE, BRIAN WILLIAM · 2005 to 2015
$2.8M
Medical Research Council G0801588NCI NIH HHS P01 CA084203NCI NIH HHS P01CA84203
6 · The paper itself

Abstract

purposeA treatment monitoring study investigated the differential effects of orthotopic pancreatic cancer models in response to interstitial photodynamic therapy (PDT), and the validity of using magnetic resonance imaging as a surrogate measure of response was assessed. METHODS AND MATERIALS: Different orthotopic pancreatic cancer xenograft models (AsPC-1 and Panc-1) were used to represent the range of pathophysiology observed in human beings. Identical dose escalation studies (10, 20, and 40J/cm) using interstitial verteporfin PDT were performed, and magnetic resonance imaging with T2-weighted and T1-weighted contrast were used to monitor the total tumor volume and the vascular perfusion volume, respectively.

resultsThere was a significant amount of necrosis in the slower-growing Panc-1 tumor using high light dose, although complete necrosis was not observed. Lower doses were required for the same level of tumor kill in the faster-growing AsPC-1 cell line.

conclusionsThe tumor growth rate and vascular pattern of the tumor affect the optimal PDT treatment regimen, with faster-growing tumors being relatively easier to treat. This highlights the fact that therapy in human beings shows a heterogeneous range of outcomes, and suggests a need for careful individualized treatment outcomes assessment in clinical work.

Indexed as

AnimalsCell Line, TumorContrast MediaFeasibility StudiesHumansMagnetic Resonance ImagingMaleMiceMice, SCIDNecrosisPancreatic NeoplasmsPhotochemotherapyPhotosensitizing AgentsPorphyrinsRadiotherapy DosageTumor BurdenContrast MediaPhotosensitizing AgentsPorphyrinsVerteporfin

Identifiers

PMID20005458
PMCPMC2902770
OpenAlexW1974820627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.